CeA treatment at the early stage of hyperglycemia-induced DM significantly reduced ppET-1 mRNA expression compared to the DM1 (p = 0.019) and DM2 (p = 0.001) groups. The gene discussed is EDN1; the disease is Hyperglycemia.